Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ampco-Pittsburgh Corp. (AP): Hedge Funds and Insiders Are Bearish, What Should You Do?

Page 1 of 2

Is Ampco-Pittsburgh Corp. (NYSE:AP) undervalued? Hedge funds are getting less bullish. The number of bullish hedge fund bets shrunk by 1 lately.

At the moment, there are plenty of gauges investors can use to analyze stocks. A couple of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite hedge fund managers can trounce the broader indices by a significant margin (see just how much).

Chuck Royce

Equally as beneficial, optimistic insider trading activity is another way to break down the investments you’re interested in. There are a number of stimuli for an insider to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Many empirical studies have demonstrated the impressive potential of this method if you know where to look (learn more here).

Consequently, let’s take a gander at the recent action encompassing Ampco-Pittsburgh Corp. (NYSE:AP).

What does the smart money think about Ampco-Pittsburgh Corp. (NYSE:AP)?

Heading into 2013, a total of 5 of the hedge funds we track held long positions in this stock, a change of -17% from the third quarter. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were upping their holdings significantly.

When looking at the hedgies we track, Chuck Royce’s Royce & Associates had the biggest position in Ampco-Pittsburgh Corp. (NYSE:AP), worth close to $27.6 million, accounting for 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Mario Gabelli of GAMCO Investors, with a $22.7 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Remaining peers that hold long positions include Jim Simons’s Renaissance Technologies, John Overdeck and David Siegel’s Two Sigma Advisors and D. E. Shaw’s D E Shaw.

Judging by the fact that Ampco-Pittsburgh Corp. (NYSE:AP) has faced falling interest from the smart money, it’s safe to say that there exists a select few funds that decided to sell off their full holdings last quarter. Intriguingly, Peter Algert and Kevin Coldiron’s Algert Coldiron Investors dropped the largest stake of the “upper crust” of funds we watch, totaling close to $0.2 million in stock. These bearish behaviors are interesting, as aggregate hedge fund interest fell by 1 funds last quarter.

How have insiders been trading Ampco-Pittsburgh Corp. (NYSE:AP)?

Insider trading activity, especially when it’s bullish, is most useful when the company in question has seen transactions within the past half-year. Over the latest six-month time frame, Ampco-Pittsburgh Corp. (NYSE:AP) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Ampco-Pittsburgh Corp. (NYSE:AP). These stocks are China Ming Yang Wind Power Group Ltd (NYSE:MY), Met-Pro Corporation (NYSE:MPR), Manitex International, Inc. (NASDAQ:MNTX), Tecumseh Products Company (NASDAQ:TECUA), and Flow International Corporation (NASDAQ:FLOW). This group of stocks are in the diversified machinery industry and their market caps resemble AP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!